AVN 54.75 Decreased By ▼ -0.72 (-1.3%)
BOP 10.65 Increased By ▲ 0.44 (4.31%)
CHCC 127.00 Decreased By ▼ -2.20 (-1.7%)
DCL 8.97 Decreased By ▼ -0.13 (-1.43%)
DGKC 102.98 Decreased By ▼ -1.77 (-1.69%)
EFERT 66.80 Decreased By ▼ -0.25 (-0.37%)
EPCL 31.25 Decreased By ▼ -0.50 (-1.57%)
FCCL 21.10 Decreased By ▼ -0.05 (-0.24%)
FFL 13.66 Increased By ▲ 0.51 (3.88%)
HASCOL 14.12 Increased By ▲ 0.48 (3.52%)
HBL 129.53 Decreased By ▼ -0.21 (-0.16%)
HUBC 81.90 Decreased By ▼ -0.70 (-0.85%)
HUMNL 9.48 Decreased By ▼ -0.03 (-0.32%)
JSCL 15.85 Increased By ▲ 0.17 (1.08%)
KAPCO 24.70 Increased By ▲ 0.35 (1.44%)
KEL 3.54 Decreased By ▼ -0.06 (-1.67%)
LOTCHEM 12.92 Decreased By ▼ -0.04 (-0.31%)
MLCF 33.00 No Change ▼ 0.00 (0%)
OGDC 112.29 Decreased By ▼ -1.26 (-1.11%)
PAEL 33.05 Decreased By ▼ -0.30 (-0.9%)
PIBTL 11.07 Decreased By ▼ -0.03 (-0.27%)
PIOC 81.00 Increased By ▲ 0.94 (1.17%)
POWER 9.11 Increased By ▲ 0.37 (4.24%)
PPL 99.25 Decreased By ▼ -0.05 (-0.05%)
PSO 181.42 Decreased By ▼ -2.10 (-1.14%)
SNGP 55.43 Decreased By ▼ -0.42 (-0.75%)
STPL 11.77 Increased By ▲ 0.22 (1.9%)
TRG 50.16 Increased By ▲ 1.81 (3.74%)
UNITY 12.60 Increased By ▲ 0.03 (0.24%)
WTL 1.05 Increased By ▲ 0.08 (8.25%)
BR100 4,150 Increased By ▲ 53 (1.28%)
BR30 21,301 Increased By ▲ 403 (1.93%)
KSE100 39,883 Increased By ▲ 305 (0.77%)
KSE30 17,298 Increased By ▲ 140 (0.82%)
COVID-19 TOTAL DAILY
CASES 281,136 675
DEATHS 6,014 15
Sindh 122,016 Cases
Punjab 93,571 Cases
Balochistan 11,780 Cases
Islamabad 15,122 Cases
KP 34,324 Cases

BEIJING: China's military has approved a coronavirus vaccine for use within its ranks that has been developed by its research unit and a biotech firm, the company said Monday.

Organisations around the world are racing to find ways to treat and prevent the deadly pathogen, which first emerged in the central Chinese city of Wuhan and has since killed over half a million people worldwide.

More than half of 17 candidate vaccines identified by the World Health Organization (WHO) that are in clinical evaluation involve Chinese companies or institutes.

Hong Kong-listed CanSino Biologics said in a filing to the stock exchange that data from clinical trials showed the Chinese military vaccine had a "good safety profile" and potential to prevent disease caused by the novel coronavirus.

CanSino said Monday that China's Central Military Commission approved the use of the vaccine on June 25, for one year.

The vaccine was jointly developed by CanSino and the Beijing Institute of Biotechnology, part of the Academy of Military Medical Sciences.

Its use cannot be expanded without further approvals, the listing said.